DanDrit Biotech to Present at, Cancer Vaccines Advancing Immuno-oncology

September 16, 2015

Dr. Eric Leire, CEO of DanDrit Biotech, will be a Speaker September 17 at 11:40 UK Time

Copenhagen, Denmark, September 17, 2015 - DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, announced that its Chief Executive Officer, Dr. Eiric Leire, will be speaking at the 4rth Cancer Vaccine Advancing Immuno-Oncology SMI conference at the Marriott Hotel Regents Park. 128 King Henry's Road London.

Read the full statement here.

Back to News